Minneapolis, MN – Dynapulse, an innovator in medical devices for circulatory and neuromuscular conditions, proudly announces its acquisition of VeinoPlus, a pioneering company known for its cutting-edge solutions in electro-stimulation therapy. This strategic acquisition underscores Dynapulse’s commitment to enhancing patient care and expanding its market presence with state-of-the-art healthcare technologies.
With the acquisition of VeinoPlus, Dynapulse aims to increase the use of their patented Second Heart technology with VeinoPlus’ advanced electro-stimulation solutions for symptoms of chronic venous insufficiency (CVI), peripheral arterial disease (PAD), Deep Vein Thrombosis (DVT) prevention, and other related medical conditions.
“This acquisition marks a significant milestone for Dynapulse, as it reinforces our mission to provide clinically supported, non-invasive treatment options to patients worldwide,” said Steffen , CEO of Dynapulse. ” VeinoPlus’ robust technology and proven efficacy in electro-stimulation perfectly align with our vision of offering comprehensive solutions that improve patients’ quality of life.”
VeinoPlus has garnered acclaim for its user-friendly, home-based treatment devices that provide effective solutions for patients. By integrating VeinoPlus’ technology and expertise, Dynapulse can now introduce its first range of products that address various circulatory and neuromuscular disorders, providing significant benefits such as improved blood circulation and pain relief.
Key Benefits of the Acquisition:
Broader Market Reach: Strengthened position in the medical devices market for circulatory and neuromuscular conditions, catering to a wider range of patient needs.
Increased Clinical Efficacy: Enhanced focus on clinically supported electro-stimulation solutions, backed by documented case studies and trusted by leading medical practitioners.
User-Friendly Solutions: An easy-to-use, home-based device that ensures patients can receive effective treatment with minimal inconvenience.
About Dynapulse
Dynapulse is an emerging medical device manufacturer specializing in circulatory and neuromuscular conditions. With a focus on innovative electro-stimulation technology, Dynapulse is committed to improving patient outcomes through clinically supported, non-invasive treatments. Their patented Second Heart technology marks the beginning of their journey towards advancing healthcare solutions.
About VeinoPlus
VeinoPlus is a leader in electro-stimulation therapy, renowned for their advanced, user-friendly devices designed to enhance patient care at home. Their technology has proven effective in addressing a range of medical conditions, making them a trusted name in the healthcare Industry.
For further details about the acquisition and future product offerings, visit our website at dynapulsemedical.com or reach out to our press contact at [email protected]